new_logo.png
Imaging Agents Market Trends 2022 | North America, Europe, & APAC Industry Forecasts 2028: Graphical Research
August 10, 2022 08:00 ET | Graphical Research
Pune, India, Aug. 10, 2022 (GLOBE NEWSWIRE) -- The global imaging agents market size is estimated to increase exponentially during the forecast period, attributed to rising demand for innovative...
Stacked logo.png
Sosei Heptares’ Oral, Selective M4 Receptor Agonist Advancing into Phase 2 Clinical Development under Multi-Program Collaboration with Neurocrine Biosciences
August 04, 2022 19:05 ET | Sosei Group Corporation
Neurocrine to conduct placebo-controlled Phase 2 study to investigate NBI-1117568 (formerly HTL-0016878) as a potential new treatment for schizophrenia Clinical development milestone triggers payment...
Odyssey Health, Inc. Launches New Corporate Website
August 04, 2022 08:00 ET | Odyssey Health, Inc
Las Vegas, NV, Aug. 04, 2022 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc., a company focused on developing unique, life-saving medical products, is...
Zeto Now Offers Remote Routine and Continuous EEG Monitoring Service to Its Customers for an Hourly Flat Rate
August 03, 2022 09:00 ET | Zeto
SANTA CLARA, Calif., Aug. 03, 2022 (GLOBE NEWSWIRE) -- Zeto, Inc., announced today that it now offers remote routine or continuous electroencephalography (EEG) monitoring services to its customers....
Stacked logo.png
Sosei Heptares and AbbVie Enter New Multi-target Collaboration to Discover, Develop and Commercialize Novel Medicines Targeting Neurological Diseases
August 01, 2022 19:05 ET | Sosei Group Corporation
New strategic collaboration leverages Sosei Heptares’ StaR® technology and SBDD platform and AbbVie’s extensive neuroscience expertise Second collaboration with AbbVie follows 2020 agreement focused...
Picture1.png
Acumen presents poster describing method to standardize amyloid beta oligomer assays supporting therapeutic development for early Alzheimer’s disease
August 01, 2022 10:30 ET | Acumen Pharmaceuticals, Inc.
CHARLOTTESVILLE, Va. and CARMEL, Ind., Aug. 01, 2022 (GLOBE NEWSWIRE) -- Scientists at Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) have developed a synthetic model to potentially standardize the...
Biogen_Logo_Standard-rgb_R.jpg
FDA Accepts Biogen’s New Drug Application and Grants Priority Review of Tofersen for a Rare, Genetic Form of ALS
July 26, 2022 07:30 ET | Biogen Inc.
SOD1-ALS is a rare genetic form of ALS that affects approximately 330 people in the U.S.,1 it is progressive, leads to the loss of everyday functions and is uniformly fatalIf approved, tofersen would...
E81DACBA-F17B-416E-96AA-C61EE583520F.png
electroCore Provides Select Second Quarter 2022 Financial Guidance
July 12, 2022 08:00 ET | electroCore, Inc.
Record revenue will be at least $2.1 million; approximately 65% growth over second quarter 2021June 30, 2022, cash and cash equivalents balance of approximately $26.6 million ROCKAWAY, N.J., July ...
ODYY-Main.png
Odyssey Health, Inc. Completes Safety Evaluation of Cohort II for Concussion Drug
June 29, 2022 08:30 ET | Odyssey Health, Inc
Las Vegas, NV, June 29, 2022 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (OTC Pink: ODYY), f/k/a Odyssey Group International, Inc., a company focused on developing unique, life-saving medical products,...
Straits Research Pvt Ltd
Catheter Market Size is projected to reach USD 88 Billion by 2030, growing at a CAGR of 6.8%: Straits Research
June 27, 2022 13:00 ET | Straits Research
New York, United States, June 27, 2022 (GLOBE NEWSWIRE) -- Medical catheters are devices that can be injected into a body cavity, vessel, or duct to give fluids, medicines, or gases or drain fluids...